Tamoxifen for patients with estrogen receptor-negative breast cancer.
Swain
S M
SM
National Cancer Institute, Bethesda, MD 20889-5105, USA. swains@mail.nih.gov
D000328:Adult; D017668:Age of Onset; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008875:Middle Aged; D016609:Neoplasms, Second Primary; D018579:Patient Selection; D011960:Receptors, Estrogen / Q000032:analysis*; D012307:Risk Factors; D013629:Tamoxifen / Q000494:pharmacology / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D011960:Receptors, Estrogen; D013629:Tamoxifen